Menu
Back to User profile » Dr Claus Werenberg Marcher
Papers published by Dr Claus Werenberg Marcher:
Psychotropic Drug Use in Acute Myeloid Leukaemia (AML) and Myelodysplastic Syndrome (MDS): A Danish Nationwide Matched Cohort Study of 2404 AML and 1307 MDS Patients
Jensen O, Øvlisen AK, Jakobsen LH, Roug AS, Nielsen RE, Marcher CW, Ebbesen Lh, Theilgaard-Mönch K, Møller P, Schöllkopf C, Torp-Pedersen C, El-Galaly TC, Severinsen MT
Clinical Epidemiology 2022, 14:225-237
Published Date: 25 February 2022
Longer distance to specialized treatment centers does not adversely affect treatment intensity or outcomes in adult acute myeloid leukemia patients. A Danish national population-based cohort study
Tøstesen M, Nørgaard M, Nørgaard JM, Medeiros BC, Marcher CW, Overgaard UM, Severinsen MT, Schoellkopf C, Østgård LSG
Clinical Epidemiology 2019, 11:769-780
Published Date: 28 August 2019
NSAID consumption and risk of acute myeloid leukemia: a national population-based case-control study
Østgård LSG, Nørgaard M, Pedersen L, Østgård R, Friis LS, Schöllkopf C, Severinsen MT, Marcher CW, Medeiros BC, Jensen MK
Cancer Management and Research 2018, 10:5043-5051
Published Date: 29 October 2018
The Danish National Acute Leukemia Registry
Østgård LSG, Nørgaard JM, Raaschou-Jensen KK, Pedersen RS, Rønnov-Jessen D, Pedersen PT, Dufva IH, Marcher CW, Nielsen OJ, Severinsen MT, Friis LS
Clinical Epidemiology 2016, 8:553-560
Published Date: 25 October 2016